R. Vanhoof

1.8k total citations
86 papers, 1.4k citations indexed

About

R. Vanhoof is a scholar working on Molecular Medicine, Epidemiology and Pharmacology. According to data from OpenAlex, R. Vanhoof has authored 86 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 38 papers in Molecular Medicine, 33 papers in Epidemiology and 26 papers in Pharmacology. Recurrent topics in R. Vanhoof's work include Antibiotic Resistance in Bacteria (38 papers), Pneumonia and Respiratory Infections (28 papers) and Antibiotics Pharmacokinetics and Efficacy (25 papers). R. Vanhoof is often cited by papers focused on Antibiotic Resistance in Bacteria (38 papers), Pneumonia and Respiratory Infections (28 papers) and Antibiotics Pharmacokinetics and Efficacy (25 papers). R. Vanhoof collaborates with scholars based in Belgium, France and Democratic Republic of the Congo. R. Vanhoof's co-authors include E. Hannecart-Pokorni, Sophie Bertrand, C. Godard, J.P. Butzler, Jan Jacobs, Marc Struelens, J. Content, A. Deplano, Ricardo De Mendonça and Y. Glupczynski and has published in prestigious journals such as PLoS ONE, Journal of Clinical Microbiology and Antimicrobial Agents and Chemotherapy.

In The Last Decade

R. Vanhoof

80 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
R. Vanhoof Belgium 21 561 502 491 276 254 86 1.4k
Camilla Wiuff United Kingdom 19 635 1.1× 261 0.5× 616 1.3× 228 0.8× 288 1.1× 34 1.6k
Lilian Pumbwe United States 18 478 0.9× 297 0.6× 307 0.6× 175 0.6× 365 1.4× 24 1.0k
R. Bywater United Kingdom 15 338 0.6× 438 0.9× 289 0.6× 304 1.1× 183 0.7× 26 1.3k
I K Wachsmuth United States 16 217 0.4× 387 0.8× 391 0.8× 270 1.0× 247 1.0× 20 1.1k
Marcelo Galas Argentina 21 667 1.2× 195 0.4× 260 0.5× 397 1.4× 214 0.8× 48 1.2k
J C Pérez-Díaz Spain 21 901 1.6× 473 0.9× 221 0.5× 461 1.7× 609 2.4× 33 2.0k
J C Pechère Switzerland 25 738 1.3× 277 0.6× 327 0.7× 232 0.8× 382 1.5× 65 1.8k
Koichi Tanimoto Japan 22 325 0.6× 348 0.7× 616 1.3× 157 0.6× 681 2.7× 59 1.5k
Nicole M. Iovine United States 17 403 0.7× 301 0.6× 891 1.8× 165 0.6× 351 1.4× 41 2.0k
Linda A. Bester South Africa 24 435 0.8× 275 0.5× 535 1.1× 130 0.5× 344 1.4× 67 1.3k

Countries citing papers authored by R. Vanhoof

Since Specialization
Citations

This map shows the geographic impact of R. Vanhoof's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R. Vanhoof with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R. Vanhoof more than expected).

Fields of papers citing papers by R. Vanhoof

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by R. Vanhoof. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R. Vanhoof. The network helps show where R. Vanhoof may publish in the future.

Co-authorship network of co-authors of R. Vanhoof

This figure shows the co-authorship network connecting the top 25 collaborators of R. Vanhoof. A scholar is included among the top collaborators of R. Vanhoof based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R. Vanhoof. R. Vanhoof is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mattheus, Wesley, Germaine Hanquet, Jean‐Marc Collard, R. Vanhoof, & Sophie Bertrand. (2015). Changes in Meningococcal Strains in the Era of a Serogroup C Vaccination Campaign: Trends and Evolution in Belgium during the Period 1997–2012. PLoS ONE. 10(10). e0139615–e0139615. 4 indexed citations
2.
Gucht, Steven Van, Jean Vanderpas, R. Vanhoof, et al.. (2013). FAVOURABLE OUTCOME IN A PATIENT BITTEN BY A RABID BAT INFECTED WITH THE EUROPEAN BAT LYSSAVIRUS-1. Acta Clinica Belgica. 68(1). 54–58. 2 indexed citations
3.
Phoba, Marie-France, Octavie Lunguya, R. Vanhoof, et al.. (2013). Epidemic increase in Salmonella bloodstream infection in children, Bwamanda, the Democratic Republic of Congo. European Journal of Clinical Microbiology & Infectious Diseases. 33(1). 79–87. 34 indexed citations
4.
Bertrand, Sophie, Eva Van Meervenne, Thierry de Baère, et al.. (2011). Detection of a geographical and endemic cluster of hyper-invasive meningococcal strains. Microbes and Infection. 13(7). 684–690. 11 indexed citations
5.
Vanhoof, R., et al.. (2011). Transmission of multiple resistant Salmonella Concord from internationally adopted children to their adoptive families and social environment: proposition of guidelines. European Journal of Clinical Microbiology & Infectious Diseases. 31(4). 491–497. 15 indexed citations
6.
Avrain, Laëtitia, M.I. Garvey, Narcisa Mesaros, et al.. (2007). Selection of quinolone resistance in Streptococcus pneumoniae exposed in vitro to subinhibitory drug concentrations. Journal of Antimicrobial Chemotherapy. 60(5). 965–972. 27 indexed citations
7.
Wildemauwe, C., C. Godard, R. De Ryck, et al.. (2006). New phage type among methicillin-resistant Staphylococcus aureus associated with a local outbreak in Belgium during 2002. Clinical Microbiology and Infection. 12(10). 1036–1038. 1 indexed citations
8.
Mesaros, Narcisa, Françoise Van Bambeke, Y. Glupczynski, R. Vanhoof, & Paul M. Tulkens. (2005). L'efflux des antibiotiques: un mécanisme ubiquitaire conduisant à la résistance. État de la question et implications microbiologiques et cliniques. Digital Access to Libraries (Université catholique de Louvain (UCL), l'Université de Namur (UNamur) and the Université Saint-Louis (USL-B)). 1 indexed citations
9.
10.
Lefèvre, Philippe, Priska Peirs, Martine Braibant, et al.. (2004). Antimycobacterial activity of synthetic pamamycins. Journal of Antimicrobial Chemotherapy. 54(4). 824–827. 18 indexed citations
11.
Wildemauwe, C., C. Godard, Gerda Verschraegen, et al.. (2003). Ten years phage-typing of Belgian clinical methicillin-resistant Staphylococcus aureus isolates (1992–2001). Journal of Hospital Infection. 56(1). 16–21. 14 indexed citations
12.
Vanhoof, R., Y. Glupczynski, B. Gordts, et al.. (2000). In Vitro Study on the Antimicrobial Activity of Various Antibiotics Against Clinical Isolates Of Streptococcus Pneumoniae From Belgium Collected During Winter 1998-1999. Acta Clinica Belgica. 55(6). 312–322. 2 indexed citations
13.
Vanhoof, R., et al.. (1999). Aminoglycoside resistance in Gram-negative blood isolates from various hospitals in Belgium and the Grand Duchy of Luxembourg. Journal of Antimicrobial Chemotherapy. 44(4). 483–488. 17 indexed citations
14.
Vanhoof, R., Y. Glupczynski, B. Gordts, et al.. (1996). In VitroSusceptibilities Of 176 Clinical Isolates OfStreptococcus Pneumoniae to11 Beta-Lactams, Erythromycin, and Tetracycline. Acta Clinica Belgica. 51(6). 377–385. 2 indexed citations
15.
Vanhoof, R., et al.. (1995). The role of lipopolysaccharide anionic binding sites in aminoglycoside uptake in Stenotrophomonas (Xanthomonas) maltophilia. Journal of Antimicrobial Chemotherapy. 35(1). 167–171. 20 indexed citations
16.
17.
Maes, Piet & R. Vanhoof. (1992). A 56-month Prospective Surveillance Study on the Epidemiology of Aminoglycoside Resistance in a Belgian General Hospital. Scandinavian Journal of Infectious Diseases. 24(4). 495–501. 13 indexed citations
18.
Staessen, Jan A., Robert Fagard, Paul Lijnen, et al.. (1991). The mean and range of the ambulatory blood-pressure in normotensive subjectes: a metaanalysis of 23 studies. Acta Clinica Belgica. 46.
19.
20.
Clumeck, Nathan, Marc Estenne, & R. Vanhoof. (1979). SEPTICEMIE ET PERITONITE 'SPONTANEE' CHEZ LE CIRRHOTIQUE. Dépôt institutionnel de l'Université libre de Bruxelles (Université Libre de Bruxelles). 8(33). 2655–2658. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Camilla Wiuff Breakdown of academic impact, for papers by Lilian Pumbwe Breakdown of academic impact, for papers by R. Bywater Breakdown of academic impact, for papers by I K Wachsmuth Breakdown of academic impact, for papers by Marcelo Galas Breakdown of academic impact, for papers by J C Pérez-Díaz Breakdown of academic impact, for papers by J C Pechère Breakdown of academic impact, for papers by Koichi Tanimoto Breakdown of academic impact, for papers by Nicole M. Iovine Breakdown of academic impact, for papers by Linda A. Bester
Rankless by CCL
2026